KALA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.865 USD | +0.71% |
|
-0.79% | -1.93% |
| Apr. 02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
| Mar. 29 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 19.2M | - | - | - | - | - | |
| 682B | ||||||
| 586B | ||||||
| 364B | ||||||
| 327B | ||||||
| 285B |
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Sector Chart